GO:1902894 negative regulation of miRNA transcription: Epigenetic Silencing, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902894 describes any process that stops, prevents, or reduces the frequency, rate, or extent of microRNA (miRNA) gene transcription.
• miRNA genes are transcribed by RNA polymerase II into primary miRNA (pri-miRNA) transcripts, and their negative regulation occurs at the level of transcription initiation and elongation.
• Epigenetic mechanisms, including histone H3K27me3 deposition and DNA methylation, are central to the negative regulation of miRNA transcription.
• Negative regulation of specific miRNAs, such as miR-1275 and miR-504, controls critical cellular decisions including glial induction and p53 tumor suppressor activity.
• In plants, the nuclear pore complex acts as a hub that couples pri-miRNA transcription with processing, revealing conserved spatial regulation of miRNA biogenesis.
• Dysregulation of negative miRNA transcription regulation is implicated in cancers, neurodegenerative diseases, and developmental disorders.
Description
MicroRNAs (miRNAs) are short non-coding RNAs that post-transcriptionally regulate gene expression, and their own production begins with transcription of miRNA genes by RNA polymerase II to generate primary miRNA (pri-miRNA) transcripts. The Gene Ontology term GO:1902894, negative regulation of miRNA transcription, encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of miRNA gene transcription. This regulatory layer is critical because the abundance of mature miRNAs is often dictated by transcriptional control rather than by processing efficiency alone. Understanding negative regulation of miRNA transcription is therefore essential for dissecting gene regulatory networks in development, immunity, and disease. Mechanistically, negative regulation of miRNA transcription can be achieved through epigenetic silencing, repressive transcription factor complexes, and chromatin remodeling. For example, the Polycomb repressive mark H3K27me3 at miRNA gene promoters mediates transcriptional silencing of miR-1275 during glial induction of glioblastoma cells. Similarly, TGF-beta signaling in triple-negative breast cancer reprograms the epigenetic landscape to alter miRNA transcription, including downregulation of specific tumor-suppressive miRNAs. These findings illustrate that negative regulation of miRNA transcription is a dynamic and context-dependent process. For researchers, GO:1902894 provides a structured framework to annotate and interrogate the transcriptional silencing of miRNA genes. Because miRNAs influence nearly every cellular pathway, identifying the factors that negatively regulate their transcription can reveal therapeutic targets and biomarkers. This article synthesizes the current understanding of GO:1902894, its molecular players, disease relevance, and experimental strategies for functional validation.
negative regulation of miRNA transcription At A Glance
| GO ID | GO:1902894 |
|---|---|
| GO term | negative regulation of miRNA transcription |
| Ontology | biological_process |
| Synonym | negative regulation of pri-miRNA transcription from RNA polymerase II promoter; inhibition of pri-miRNA transcription from RNA polymerase II promoter; negative regulation of microRNA gene transcription |
| Major function | Reduces or prevents transcription of miRNA genes by RNA polymerase II, thereby controlling mature miRNA levels |
| Related process | Epigenetic silencing via histone modifications and DNA methylation |
| Cellular context | Nucleus, at miRNA gene promoters and associated chromatin |
| Key regulators | Transcription factors, Polycomb complexes, DNA methyltransferases, signaling pathways such as TGF-beta |
What Is GO:1902894?
GO:1902894 (negative regulation of miRNA transcription) is a biological process defined as any process that stops, prevents, or reduces the frequency, rate, or extent of microRNA (miRNA) gene transcription. It specifically refers to the downregulation of pri-miRNA transcription from an RNA polymerase II promoter, encompassing both direct inhibition of the transcriptional machinery and upstream signaling events that lead to reduced miRNA gene expression.
Why Is negative regulation of miRNA transcription Important in Cell Biology?
Negative regulation of miRNA transcription is a fundamental control point in gene expression because it determines the available pool of pri-miRNA transcripts for processing into mature miRNAs. Since miRNAs modulate diverse biological processes including cell differentiation, immune responses, and tumor suppression, the ability to silence miRNA genes transcriptionally provides a powerful mechanism for cells to rapidly and stably alter their regulatory landscape. Dysregulation of this process contributes to cancer, neurodegeneration, and developmental abnormalities, making it a high-value area for both basic research and therapeutic intervention.
• Controls the first step of miRNA biogenesis, thereby influencing the entire downstream miRNA regulatory network.
• Enables epigenetic silencing of oncogenic or tumor-suppressive miRNAs in cancer.
• Regulates immune cell responses, as shown for miRNA transcription in macrophages exposed to Candida albicans.
• Modulates p53 tumor suppressor activity through negative regulation of miR-504 transcription.
• Plays a role in glial differentiation and glioblastoma pathogenesis via H3K27me3-mediated silencing of miR-1275.
• Is linked to TGF-beta signaling and triple-negative breast cancer progression.
• In plants, couples pri-miRNA transcription with nuclear pore complex-mediated processing.
• Has implications for Alzheimer's disease through posttranscriptional regulation of Nrf2 by miRNAs.
• Provides potential therapeutic targets for reactivating silenced tumor-suppressive miRNAs.
• Serves as a paradigm for understanding how transcription and processing are spatially and temporally coordinated.
What Happens During negative regulation of miRNA transcription?
Initiation of miRNA gene transcription and its repression
In simple terms: Cells first start reading miRNA genes to make pri-miRNA, and negative regulation stops this reading process.
miRNA genes are transcribed by RNA polymerase II to produce pri-miRNA transcripts. Negative regulation of miRNA transcription can occur at the level of initiation, where repressive transcription factors or chromatin modifications prevent RNA polymerase II recruitment to miRNA gene promoters. For example, in macrophages responding to Candida albicans, specific miRNA transcription is downregulated as part of the immune response. This step is critical because it sets the upper limit for mature miRNA production.
Epigenetic silencing through histone modifications
In simple terms: Chemical tags on histone proteins can tighten DNA packaging and shut down miRNA genes.
Repressive histone modifications, particularly H3K27me3, are deposited at miRNA gene promoters to mediate transcriptional silencing. In glioblastoma cells, H3K27me3 at the miR-1275 locus is critical for glial induction, demonstrating that negative regulation of miRNA transcription is required for differentiation. Similarly, TGF-beta signaling in triple-negative breast cancer alters the epigenetic landscape, leading to changes in miRNA transcription. These modifications provide a stable and heritable mechanism for miRNA gene repression.
DNA methylation and long-term silencing
In simple terms: Methyl groups added to DNA can lock miRNA genes in an off state.
DNA methylation of CpG islands within miRNA gene promoters is another mechanism for negative regulation of miRNA transcription. In triple-negative breast cancer, TGF-beta signaling induces epigenetic changes that include methylation-mediated silencing of specific miRNAs. This form of regulation is often associated with long-term transcriptional repression and can be reversed by DNA methyltransferase inhibitors.
Coupling of transcription repression with pri-miRNA processing
In simple terms: In plants, the machinery that makes pri-miRNA is physically linked to the machinery that processes it, and negative regulation can affect both.
The nuclear pore complex acts as a hub for pri-miRNA transcription and processing in plants, indicating that negative regulation of miRNA transcription may be coordinated with downstream processing events. This spatial coupling ensures that transcriptional output and processing efficiency are balanced. Disruption of this coupling can lead to altered miRNA levels and developmental defects.
Signaling pathways that trigger negative regulation
In simple terms: External signals can tell cells to shut down specific miRNA genes.
Signaling pathways such as TGF-beta can reprogram miRNA transcription by activating repressive transcription factors or epigenetic modifiers. In macrophages, exposure to Candida albicans leads to downregulation of specific miRNAs, demonstrating pathogen-responsive negative regulation of miRNA transcription. These signaling events allow cells to rapidly adapt their miRNA repertoire to environmental cues.
Key Genes Involved in GO:1902894 negative regulation of miRNA transcription
The following genes and proteins are experimentally implicated in the negative regulation of miRNA transcription, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EZH2 | Catalytic subunit of Polycomb repressive complex 2 that deposits H3K27me3 at miRNA gene promoters | Mediates silencing of miR-1275 during glial induction in glioblastoma |
| SUZ12 | Core component of PRC2 required for H3K27me3-mediated miRNA gene repression | Essential for epigenetic silencing of miRNA genes in cancer and differentiation |
| DNMT1 | DNA methyltransferase that maintains CpG methylation at miRNA promoters | Contributes to long-term silencing of miRNAs in triple-negative breast cancer |
| DNMT3A | De novo DNA methyltransferase that establishes new methylation marks | Involved in TGF-beta-induced epigenetic reprogramming of miRNA transcription |
| SMAD2/3 | TGF-beta signaling effectors that can recruit repressive complexes to miRNA genes | Mediate TGF-beta-dependent negative regulation of miRNA transcription in breast cancer |
| TP53 | Tumor suppressor that can indirectly repress miRNA transcription through downstream effectors | Its activity is modulated by miR-504, whose transcription is negatively regulated |
| miR-1275 | miRNA whose transcription is negatively regulated by H3K27me3 | Critical for glial induction of glioblastoma cells |
| miR-504 | miRNA that negatively regulates p53 and is itself subject to transcriptional control | Provides a feedback loop in p53 regulation |
| NUP98 | Nuclear pore complex component involved in pri-miRNA transcription and processing | Links transcription repression to processing in plants |
| NUP160 | Nuclear pore complex protein that acts as a hub for pri-miRNA biogenesis | Required for proper miRNA levels in plants |
| NRF2 | Transcription factor regulated by miRNAs; its own regulation involves miRNA transcription | Implicated in Alzheimer's disease through miRNA-mediated posttranscriptional control |
| FOXP3 | Transcription factor in regulatory T cells that can influence miRNA gene expression | Regulatory T cell function involves miRNA-mediated gene regulation |
| Candida albicans-responsive TFs | Transcription factors that downregulate miRNA genes in macrophages | Model for pathogen-induced negative regulation of miRNA transcription |
| RNA polymerase II | Core enzyme responsible for pri-miRNA transcription; its recruitment is inhibited during negative regulation | Central target of repressive mechanisms |
| H3K27me3 readers | Proteins that bind H3K27me3 and maintain repressive chromatin at miRNA loci | Potential drug targets for reactivating silenced miRNAs |
| TGF-beta receptor complex | Upstream signaling that triggers epigenetic silencing of miRNAs | Therapeutic target in triple-negative breast cancer |
| AGO1 | Argonaute protein involved in miRNA processing and function; may feedback on transcription | Studied in plant miRNA biogenesis |
| DCL1 | Plant RNase III enzyme that processes pri-miRNA; coupled with transcription | Model for transcription-processing coupling |
How Is negative regulation of miRNA transcription Regulated?
Negative regulation of miRNA transcription is itself controlled by upstream signaling pathways and epigenetic modifiers. TGF-beta signaling activates SMAD transcription factors that recruit repressive complexes to miRNA gene promoters, leading to H3K27me3 deposition and DNA methylation. In macrophages, pathogen recognition triggers signaling cascades that downregulate specific miRNA genes as part of the immune response. The Polycomb repressive complex 2 (PRC2), containing EZH2 and SUZ12, is a key executor of H3K27me3-mediated silencing at miRNA loci. Additionally, the nuclear pore complex in plants coordinates pri-miRNA transcription with processing, suggesting that spatial organization regulates the efficiency of negative regulation. These layers of control ensure that miRNA gene silencing is responsive to developmental and environmental cues.
negative regulation of miRNA transcription and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EZH2 | Glioblastoma, epigenetic silencing of miR-1275 | Knockout or point mutation in glioblastoma cell lines; H3K27me3 ChIP-seq |
| SMAD2/3 | Triple-negative breast cancer, TGF-beta signaling | Knockout in TNBC cell lines; RNA-seq and methylation arrays |
| TP53 | Cancer, p53 feedback loop with miR-504 | Knock-in of miR-504 binding site mutations; luciferase reporter assays |
| NUP98 | Plant development, pri-miRNA transcription-processing coupling | Knockout in Arabidopsis; small RNA-seq and imaging |
| NRF2 | Alzheimer's disease, oxidative stress | Overexpression or knockout in neuronal cell lines; miRNA profiling |
Cancer
Negative regulation of miRNA transcription is frequently dysregulated in cancer. In triple-negative breast cancer, TGF-beta signaling induces epigenetic silencing of tumor-suppressive miRNAs through DNA methylation and histone modifications. In glioblastoma, H3K27me3-mediated negative regulation of miR-1275 transcription is critical for glial induction, and its disruption contributes to tumorigenesis. The p53 tumor suppressor network is also modulated by miR-504, whose transcription is negatively regulated, creating a feedback loop that affects cancer cell survival.
Neurodegenerative diseases
In Alzheimer's disease, posttranscriptional regulation of Nrf2 by miRNAs is implicated in oxidative stress responses, and the transcription of these miRNAs is subject to negative regulation. This suggests that altered negative regulation of miRNA transcription could contribute to neurodegeneration by disrupting Nrf2-mediated cytoprotection.
Immune and inflammatory disorders
Macrophage responses to Candida albicans involve negative regulation of miRNA transcription, highlighting a role in host-pathogen interactions. Regulatory T cell differentiation and function, which are essential for immune tolerance, are influenced by miRNA-mediated gene regulation. Dysregulation of these processes can lead to autoimmunity or immunodeficiency.
Developmental disorders
In plants, the nuclear pore complex couples pri-miRNA transcription with processing, and disruption of this coupling leads to developmental defects. Plant miRNAs are essential for development, and their negative regulation must be precisely controlled. While plant and animal systems differ, the principle that negative regulation of miRNA transcription is critical for development is conserved.
From negative regulation of miRNA transcription-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does EZH2-mediated H3K27me3 directly repress miR-1275 transcription? | EZH2 knockout glioblastoma cells with H3K27me3 ChIP and pri-miR-1275 qPCR |
| How does TGF-beta signaling alter miRNA transcription in TNBC? | SMAD2/3 knockout TNBC cells treated with TGF-beta, followed by RNA-seq and MeDIP-seq |
| Is the miR-504 promoter directly regulated by p53? | p53 knockout or point-mutant cells with miR-504 promoter reporter assays |
| What is the role of nuclear pore complex in pri-miRNA transcription? | NUP98 knockout Arabidopsis plants with small RNA-seq and FISH |
| Does Candida albicans infection downregulate specific miRNAs in macrophages? | Macrophage cell line with Candida albicans challenge and miRNA qPCR |
| Can reactivation of silenced miRNAs be achieved by epigenetic drugs? | Cancer cell lines treated with DNMT or HDAC inhibitors, followed by miRNA profiling |
How to Study the negative regulation of miRNA transcription Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide binding of repressive marks and transcription factors at miRNA promoters | Identifying H3K27me3-enriched miRNA loci in cancer |
| RNA-seq | Steady-state levels of pri-miRNA and mature miRNA transcripts | Detecting transcriptional downregulation of miRNAs upon treatment |
| Small RNA-seq | Mature miRNA expression profiles | Quantifying miRNA changes in knockout models |
| Bisulfite sequencing | DNA methylation status of miRNA gene promoters | Assessing epigenetic silencing in TNBC |
| Luciferase reporter assay | Promoter activity in response to repressors | Validating direct repression of miR-504 promoter |
| CRISPR knockout | Loss-of-function of candidate repressors | Testing EZH2 requirement for miR-1275 silencing |
| CRISPR activation (CRISPRa) | Reactivation of silenced miRNA genes | Therapeutic potential in cancer |
| Proteomics | Protein complexes associated with miRNA gene promoters | Identifying nuclear pore complex components in pri-miRNA regulation |
Chromatin immunoprecipitation followed by sequencing (ChIP-seq)
ChIP-seq for H3K27me3, H3K9me3, or RNA polymerase II is used to map repressive marks and polymerase occupancy at miRNA gene promoters. This method identifies which miRNA loci are subject to negative regulation and which epigenetic modifiers are involved.
RNA sequencing and small RNA sequencing
RNA-seq measures pri-miRNA and mature miRNA levels, allowing researchers to infer transcriptional repression when pri-miRNA levels decrease. Small RNA-seq specifically quantifies mature miRNAs, and the ratio of pri-miRNA to mature miRNA can indicate whether negative regulation occurs at the transcriptional or processing level.
DNA methylation analysis
Bisulfite sequencing or methylation-specific PCR can detect CpG methylation at miRNA gene promoters, which is a hallmark of long-term negative regulation of miRNA transcription. This approach is particularly useful in cancer studies where epigenetic silencing is common.
Reporter assays and CRISPR-based promoter editing
Luciferase reporters driven by miRNA gene promoters are used to test whether specific transcription factors or epigenetic modifiers repress promoter activity. CRISPR-mediated deletion or mutation of predicted repressive elements can confirm their functional relevance in the native chromatin context.
How CRISPR Can Be Used to Study GO:1902894 negative regulation of miRNA transcription
Knockout
CRISPR knockout of candidate repressors such as EZH2 or SMAD2/3 can determine whether they are required for negative regulation of specific miRNA genes. For example, EZH2 knockout in glioblastoma cells leads to loss of H3K27me3 at the miR-1275 locus and increased pri-miR-1275 transcription.
Point Mutation
Point mutations can be introduced into miRNA gene promoters to disrupt repressive transcription factor binding sites or epigenetic marks. This allows precise mapping of the cis-elements required for negative regulation of miRNA transcription.
Knock-in
Knock-in of tagged versions of repressive complex components, such as EZH2-FLAG, enables chromatin immunoprecipitation and proteomic studies to identify interacting partners at miRNA loci. Knock-in of reporter cassettes into miRNA gene loci can also provide real-time readouts of transcriptional repression.
Overexpression
Overexpression of candidate repressors or signaling pathway components, such as constitutively active SMAD2/3, can induce negative regulation of miRNA transcription and reveal downstream effects. Conversely, overexpression of a miRNA gene itself can be used to rescue phenotypes caused by loss of negative regulation.
How EDITGENE Supports negative regulation of miRNA transcription Research
Researchers studying negative regulation of miRNA transcription-related genes often need to determine whether a candidate gene is causally involved in silencing specific miRNA loci. EDITGENE provides comprehensive CRISPR-based services to enable precise genetic manipulation and functional validation in this field.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of miRNA transcription research.
Frequently Asked Questions About negative regulation of miRNA transcription
What is negative regulation of miRNA transcription?
It is any process that stops, prevents, or reduces the transcription of microRNA genes by RNA polymerase II, as defined by GO:1902894.
What genes are involved in negative regulation of miRNA transcription?
Key genes include EZH2, SUZ12, DNMT1, DNMT3A, SMAD2/3, and TP53, which mediate epigenetic silencing or signaling-induced repression of miRNA genes.
How is miRNA transcription negatively regulated?
It occurs through epigenetic mechanisms such as H3K27me3 deposition, DNA methylation, and repressive transcription factor complexes at miRNA gene promoters.
What diseases are associated with negative regulation of miRNA transcription?
Cancers such as glioblastoma and triple-negative breast cancer, neurodegenerative diseases like Alzheimer's, and immune disorders.
What is the role of H3K27me3 in miRNA transcription?
H3K27me3 is a repressive histone mark that silences miRNA genes, as shown for miR-1275 in glioblastoma cells.
How can I study negative regulation of miRNA transcription?
Use ChIP-seq, RNA-seq, small RNA-seq, bisulfite sequencing, and CRISPR knockout models to map repressive marks and measure miRNA levels.
What is the difference between pri-miRNA and mature miRNA?
Pri-miRNA is the primary transcript produced by RNA polymerase II, while mature miRNA is the processed functional form; negative regulation of transcription reduces pri-miRNA levels.
Can CRISPR be used to study negative regulation of miRNA transcription?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of repressors and cis-elements.
What signaling pathways regulate miRNA transcription negatively?
TGF-beta signaling and pathogen-responsive pathways in macrophages are known to induce negative regulation of miRNA transcription.
Why is negative regulation of miRNA transcription important in cancer?
It controls the expression of tumor-suppressive or oncogenic miRNAs, and its dysregulation contributes to cancer progression.
Conclusion
GO:1902894, negative regulation of miRNA transcription, represents a critical layer of gene control that determines the availability of miRNA precursors. Through epigenetic silencing, repressive transcription factors, and signaling-induced changes, cells can dynamically shut down specific miRNA genes. This process is essential for normal development and immune function, and its dysregulation is implicated in cancer, neurodegeneration, and other diseases. Continued research using CRISPR-based models and multi-omics approaches will further illuminate the mechanisms and therapeutic potential of targeting negative regulation of miRNA transcription.
References
- 1. Josefowicz SZ et al.. 2012. Regulatory T cells: mechanisms of differentiation and function.. Annu Rev Immunol 30:531-64 PMID: 22224781
- 2. Monk CE et al.. 2010. Regulation of miRNA transcription in macrophages in response to Candida albicans.. PLoS One 5(10):e13669 PMID: 21060679
- 3. Vishnubalaji R et al.. 2021. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.. Sci Rep 11(1):15410 PMID: 34326372
- 4. Mai J et al.. 2019. Negative regulation of miR-1275 by H3K27me3 is critical for glial induction of glioblastoma cells.. Mol Oncol 13(7):1589-1604 PMID: 31162799
- 5. Hu W et al.. 2010. Negative regulation of tumor suppressor p53 by microRNA miR-504.. Mol Cell 38(5):689-99 PMID: 20542001
- 6. Jover-Gil S et al.. 2005. Plant microRNAs and development.. Int J Dev Biol 49(5-6):733-44 PMID: 16096978
- 7. Gonzalo L et al.. 2025. The nuclear pore complex acts as a hub for pri-miRNA transcription and processing in plants.. Nucleic Acids Res 53(17) PMID: 40966524
- 8. Kaundal RK et al.. 2022. Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer's disease.. Pharmacol Res 175:106018 PMID: 34863823
